ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
International Journal of Pharmaceutics
Volume 350, Issues 1-2, 28 February 2008, Pages 14-26
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (712 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.ijpharm.2007.11.012    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2007 Elsevier B.V. All rights reserved.

Historical Perspectives

How to achieve sustained and complete protein release from PLGA-based microparticles?

A. Giteaua, b, M.C. Venier-Juliennea, b, Corresponding Author Contact Information, E-mail The Corresponding Author, A. Aubert-Pouësselc and J.P. Benoita, b

aINSERM, U646, Angers F-49100, France bUniversité d’Angers, Angers F-49100, France cUMR 5253 CNRS,UM2,ENSCM,UM1, Montpellier F-34296, France

Received 31 July 2007; 
revised 6 November 2007; 
accepted 8 November 2007. 
Available online 17 November 2007.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

One of the most challenging tasks in the delivery of therapeutic proteins from PLGA-based microparticles is the sustained and complete release of the protein in its native form. The mechanisms responsible for incomplete protein release from these devices are numerous and complex; the beneficial effect of different formulations has often been evaluated in vitro. Strategies employed for overcoming protein destabilization during the release step are reviewed in this paper. Proteins have been protected in the deleterious environment by adding stabilizers to the formulation, or by modifying the protein or the polymer. Alternatively, some strategies have aimed at avoiding the formation of the destabilizing environment. As experimental conditions may influence the results from in vitro release studies, we initially report precautions to avoid adverse effects.

Keywords: Sustained release; Protein; Microspheres; Poly(lactic-co-glycolic acid) (PLGA); In vitro release; Release mechanism

Article Outline

1. Introduction
2. Influence of the experimental conditions on the release profile
2.1. Influence of the release medium
2.2. Influence of the sampling method
3. Trends toward a sustained and complete release
3.1. Stabilizing proteins in the deleterious environment
3.1.1. Protein chemical modification
3.1.2. Neutralization of PLGA degradation products
3.1.3. Help to protein refolding
3.1.4. Formation of a viscous microenvironment
3.1.5. Use of a more hydrophilic polymer
3.2. Preventing the formation of the deleterious environment
3.2.1. Delay of polymer degradation
3.2.2. Preparation of porous microspheres
3.2.3. Minimization of the protein–polymer surface area
4. Conclusion
References






 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.